@prefix p: <http://www.wikidata.org/prop/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema1: <http://schema.org/> .
@prefix wd: <http://www.wikidata.org/entity/> .
@prefix wds: <http://www.wikidata.org/entity/statement/> .
@prefix wdt: <http://www.wikidata.org/prop/direct/> .
@prefix wikibase: <http://wikiba.se/ontology#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

wd:Q64790189 rdfs:label "Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease"@en ;
    schema1:dateModified "2025-02-16T11:42:10+00:00"^^xsd:dateTime ;
    schema1:description "تجربة سريرية"@ar,
        "ensayu clínicu"@ast,
        "assaig clínic"@ca,
        "clinical trial"@en,
        "clinical trial"@en-ca,
        "clinical trial"@en-gb,
        "clinical trial"@en-us,
        "klinika studo"@eo,
        "ensayo clínico"@es,
        "essai clinique"@fr,
        "ensaio clínico"@gl,
        "կլինիկական փորձարկում"@hy,
        "studio clinico"@it,
        "治験"@ja,
        "임상시험"@ko,
        "klinisch onderzoek"@nl,
        "ensaio clínico"@pt,
        "ensaio clínico"@pt-br,
        "клиническое исследование"@ru,
        "klinické štúdie"@sk,
        "клінічне випробування"@uk,
        "thử nghiệm lâm sàng"@vi,
        "临床试验"@zh,
        "临床试验"@zh-hans,
        "臨床試驗"@zh-hant ;
    schema1:version 2312316171 ;
    wikibase:identifiers 1 ;
    wikibase:sitelinks 0 ;
    wikibase:statements 21 ;
    p:P1476 wds:Q64790189-825AEA6F-9802-4930-A5E0-8C362A1AB97E ;
    p:P17 wds:Q64790189-9F232B86-6366-41ED-8141-A62DE711B6C0 ;
    p:P2899 wds:Q64790189-49159B9D-40CC-4145-83BD-1B46CFA1FF9B ;
    p:P3098 wds:Q64790189-528764CB-CD21-42F2-9AE8-62312001530A ;
    p:P31 wds:Q64790189-54B1DD1A-7CF5-4D2E-9FF3-F363838A3CC1 ;
    p:P6153 wds:Q64790189-122BABD5-60F6-49FB-89A7-3E97E46E4A9A,
        wds:Q64790189-1EFA6AB2-B8A2-4C6D-B436-AE39E87883E2,
        wds:Q64790189-2C98587D-87BE-4463-9816-D66559E5D0AA,
        wds:Q64790189-32F83C48-E9ED-422F-8681-A7AF8590D04E,
        wds:Q64790189-32F9CF71-E1FB-4223-A668-1537138484CF,
        wds:Q64790189-59770D58-E97D-4740-8237-ECD70CDA0DE7,
        wds:Q64790189-60FAA7DE-5BBD-490F-9B84-8441875265D5,
        wds:Q64790189-7613790F-2372-4241-9529-4FCAB5E914AE,
        wds:Q64790189-7AEC93BF-A18C-4523-B427-68D9E03ECF4A,
        wds:Q64790189-8CEFCE1C-3B8D-4C00-8C29-0B9465DDA99D,
        wds:Q64790189-BACAB61F-3004-4AFD-9127-1F7B1FF24DE2,
        wds:Q64790189-D6930851-C8B4-4551-AB31-BBF0BB1F4D14,
        wds:Q64790189-DC3D3C00-5D8E-4767-A8D5-153E5F083B26,
        wds:Q64790189-E577CA6D-8E76-45D3-9307-05A5A05ADA96,
        wds:Q64790189-ED0A4C78-0DA5-4424-B07C-28094510B90B ;
    p:P8363 wds:Q64790189-176A01D7-7E5B-43F9-8B1A-5E0D8247B355 ;
    wdt:P1476 "An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease"@en ;
    wdt:P17 wd:Q30 ;
    wdt:P2899 2.0 ;
    wdt:P3098 "NCT02596997" ;
    wdt:P31 wd:Q30612 ;
    wdt:P6153 wd:Q1048851,
        wd:Q131252,
        wd:Q1353679,
        wd:Q1452369,
        wd:Q1468161,
        wd:Q2725999,
        wd:Q30254344,
        wd:Q4117596,
        wd:Q41506,
        wd:Q501758,
        wd:Q5098129,
        wd:Q5098193,
        wd:Q622664,
        wd:Q6806307,
        wd:Q777403 ;
    wdt:P8363 wd:Q407954 .